参考文献/References:
1 Verdile G,Fuller S,Atwood CS,et al.The role of beta amyloid in Alzheimer’s disease:still a cause of everything or the only one who got caught.Pharmacol Res,2004,50(4):397-409.
2 Court JA,Piggott MA,Lloyd S,et al.Nicotine binding in human striatum:elevation in schizophrenia and reductions in dementia with Lewy bodies,Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication.Neurosci,2000,98(1):79-87.
3 Nora DV,Ding YS,Joanna SF,et al.Imaging brain cholinergic activity with positron emission tomography:its role in the evaluation of cholinergic treatments in Alzheimer’s dementia.Biol Psychiatry,2001,49(3):211-220.
4 De Leon MJ,Convit A,Wolf OT,et al.Prediction of cognitive decline in normal elderly subjects with 2-[18F] fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).Proc Natl Acad Sci USA,2001,98(19):10966-10971.
5 Hard J,Selkoe DJ.The amyloid hypothesis of Alzheimer’s disease:progress and problems on the road to therapeutics.Science,2002,297(5590):353-356.
6 Zhang Y,Pavlova OA,Chefer SI,et al.5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy) pyridine with low picomolar affinity for alpha 4 beta 2 nicotinic acetylcholine receptor and wide range of lipophilicity:potential probes for imaging with positron emission tomography.J Med Chem.2004,47(10):2453-2465.
7 Mathis CA,Bacskai BJ,Kajdasz ST,et al.A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain.Bioorg Med Chem Lett,2002,12(3):295-298.
8 Klunk WE,Engler H,Nordberg A,et al.Imaging brain amyloid in Alzheimer’s disease with pittsburgh compound-B.Ann Neurol,2004,55(3):306-319.
9 Kung HF,Lee CW,Zhuang ZP,et al.Novel stilbenes as probes for amyloid plaques.J Am Chem Soc,2001,123(50):12740-12741.
10 Suemoto T,Okamura N,Shiomostu T,et al.In vivo labeling of amyloid with BF-108.Neurosci Res,2004,48(1).65-74.
11 Agdeppa ED,Kepe V,Liu J,et al.In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer’s brain using the positron emission tomography molecular imaging probe2-(1-[6-[(2-[18F]fluoroethyl) (methyl)amino]-2-naphthyl] ethylidene) malononitrile.Neurosci,2003,117(3):723-730.
12 Musachio JL,Flesher J,Scheffel UA,et al.Radiosynthesis and mouse brain distribution studies of 11C-CP-126,998:a PET ligand for in vivo study of acetylcholinesterase.Nucl Med Biol,2002,29(5):547-552.
13 Zhang MR,Tsuchiyama A,Haradahira T,et al.Synthesis and preliminary evaluation of[18F] FEtP4A,a promising PET tracer for mapping acetylcholinesterase in vivo.Nucl Med Biol,2002,29(4):463-468.
14 Shao X,Lisi JM,Butch ER,et al.N-[18F] fluoroethylpiperidinyl,N-[18F] fluoroethylpiperidinemethyl and N-[18F] fluoroethylpyrrolidinyl esters as radiotracers for acetylcholinesterase.Nucl Med Biol,2003,30(5):491-500.
15 Skaddan MB,Sherman PS,Kilbourn,MR,et al.The role of species-dependent metabolism in the regional brain retention of 18F-labeled muscarinic acetylcholine receptor ligands.Nucl Med Biol,2001,28(7):753-759.
16 Cohen VI,Jin BJ,McRee RC,et al.In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiasepinones and pyridobenzodiazepinones.Brain Res,2000,861(2):305-315.
17 Piggott M,Owens J,O’Brien J,et al.Comparative distribution of binding of the muscarinic receptor ligands pirenzepine,AF-DX 384,(R,R)-I-QNB and (R,S)-I-QNB to human brain.J Chem Neuroanat,2002,24(3):211-223.
18 Koren AO,Horti AG,Mukhin AG,et al.2-,5-,and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines:synthesis,affinity for nicotinic acetylcholinereceptors,and molecular modeling.J Med Chem,1998,41(19):3690-3698.
19 Horti AG,Chefer SL,Mukhin AG,et al.6-[18F] fluoro-A-85380,a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors.Life Sci,2000,67(4):463-469.
20 Roger G,Lagnel B,Rouden J,et al.Synthesis of a[2-pyridinyl-18F]-labelled fluoro derivative of (-)-cytisine as a candidate radioligand for brain nicotinic alpha4beta2 receptor imaging with PET.Bioorg Med Chem,2003,11(24):5333-5343.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[4]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[5]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[6]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[7]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[8]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[9]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[10]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[11]陈贵兵,吴华,彭添兴.正电子显像剂11C-匹兹堡化合物B的化学合成及其临床应用[J].国际放射医学核医学杂志,2008,32(3):158.
CHEN Gui-bing,WU Hua,PENG Tian-xing.Chemical synthesis and clinical application of a new positron imaging agent 11C-Pittsburgh compound-B[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):158.
[12]郭喆,张锦明.阿尔茨海默病的放射性分子显像探针研究进展[J].国际放射医学核医学杂志,2006,30(4):199.
GUO Zhe,ZHANG Jin-ming.Study on radioactive labeling of molecular probes for Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):199.
[13]李祖贵.轻度认知障碍的功能性神经影像学研究进展[J].国际放射医学核医学杂志,2006,30(2):76.
LI Zu-gui.The progress of functional neuroimaging in the study of mild cognitive impairment[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):76.